TABLE 2.
Cytokines | Controls (n = 14) | COVID-19 cases (n = 22) | SIDAK adjusted P-value | Odds A/1–A | |
1 | IL-10 | 6.6 | 33.02 | 0.000 | 101.67 |
2 | IL-6 | 3.17 | 37.52 | 0.000 | 50.33 |
3 | PDGF-AB-BB | 649.57 | 2128.06 | 0.000 | 24.67 |
4 | IP10 | 266.59 | 1090.44 | 0.000 | 21 |
5 | IL-1RA | 19.7 | 147.6 | 0.002 | 9.27 |
6 | sCD40L | 93.44 | 262.76 | 0.003 | 8.33 |
7 | TNFα | 5.85 | 15.21 | 0.007 | 6.9 |
8 | IL-8 | 6.76 | 15.55 | 0.011 | 6.16 |
9 | MCP-1 | 251.09 | 509.79 | 0.012 | 6 |
10 | IL-4 | 20.19 | 49.47 | 0.053 | 4.36 |
11 | MDC | 588.7 | 358.31 | 0.055 | 4.31 |
12 | MCP-3 | 20.91 | 68.9 | 0.057 | 4.27 |
13 | FGF-2 | 83.51 | 120.66 | 0.105 | 3.74 |
14 | Flt-3L | 29.73 | 21.62 | 0.225 | 3.16 |
15 | IL-1α | 0.53 | 8.85 | 0.198 | 3.13 |
16 | PDGF-AA | 59.08 | 228.51 | 0.237 | 3.11 |
17 | GCSF | 52.5 | 73.67 | 0.301 | 2.92 |
18 | IL-7 | 1.38 | 5.31 | 0.601 | 2.4 |
19 | GROα | 217 | 1012.19 | 0.645 | 2.35 |
20 | IL-15 | 2.94 | 5.22 | 0.645 | 2.35 |
21 | IFNγ | 3.64 | 7.65 | 0.712 | 2.23 |
22 | Fractaline | 125.66 | 151.76 | 0.820 | 2.07 |
23 | IL-13 | 4.5 | 10.34 | 0.914 | 1.89 |
24 | MIP-1β | 12.92 | 10.34 | 0.940 | 1.81 |
25 | GM-CSF | 3.19 | 4.74 | 0.940 | 1.78 |
26 | IL-1β | 0.08 | 0.22 | 0.940 | 1.74 |
27 | TNFB | 3.86 | 19.28 | 0.961 | 1.68 |
28 | IL-12p70 | 0.52 | 1.67 | 0.961 | 1.67 |
29 | IL-12p40 | 10.43 | 13.75 | 0.968 | 1.6 |
30 | IL-2 | 0.41 | 1 | 0.961 | 1.59 |
31 | RANTES | 924.91 | 898.61 | 0.969 | 1.57 |
32 | IL-3 | 0.82 | 1.39 | 0.987 | 1.45 |
33 | IL-5 | 1.49 | 0.93 | 0.999 | 1.27 |
34 | IL-17A | 5.22 | 4.18 | 0.999 | 1.27 |
35 | TGF-α | 1.09 | 0.85 | 0.999 | 1.26 |
36 | VEGF | 47.79 | 34.26 | 0.999 | 1.26 |
37 | MIP-1α | 9.92 | 9.25 | 0.999 | 1.22 |
38 | Eotaxin | 156.91 | 146.36 | 0.999 | 1.15 |
39 | EGF | 30.48 | 20.97 | 0.999 | 1.14 |
40 | IFNα2 | 15.75 | 16.28 | 0.999 | 1.05 |
41 | IL-9 | 0.87 | 0.87 | 0.999 | 1.05 |